期刊文献+

前列地尔治疗急性大脑中动脉闭塞性脑梗死患者疗效的对比观察 被引量:4

The effect of alprostadil on acute cerebral infarction caused by middle cerebral artery arterial occlusion
下载PDF
导出
摘要 目的观察前列地尔治疗急性大脑中动脉闭塞性脑梗死患者的临床疗效。方法将112例经脑血管造影证实为大脑中动脉闭塞性所致的急性脑梗死患者随机分为两组,对照组55例,采用常规治疗;治疗组57例,在常规治疗基础上加用前列地尔脂微球载体制剂10μg,静脉点滴,1次/d,14 d为一疗程。评价治疗前后神经功能缺损评分的变化及疗效,监测用药前后脑出血等并发症的发生情况及凝血功能、肝肾功能的变化。结果治疗组治疗后14 d、28 d NIHSS评分较对照组明显减少,差异有统计学意义(P<0.05);两组治疗后BI评分均较治疗前增加(P<0.05),治疗组治疗后BI评分增加较对照组差异有统计学意义(P<0.05);两组治疗后ADL评分均减少(P<0.05),治疗组治疗后ADL评分减少较对照组差异有统计学意义(P<0.05);两组不良事件发生情况无明显差异。结论大脑中动脉闭塞所致的急性脑梗死患者病情较重,治疗效果差;前列地尔脂微球载体制剂治疗颅内动脉狭窄所致的急性脑梗死患者安全有效。 Objective To study the effect of alprostadil on acute cerebral int:arction caused by iniddie cerebral artery arterial occlusion. Methods 112 cases those confirmed as acute cerebral infarction caused by middle cerebral artery occlusion through cerebral angiography, were divided into two groups randomly. Patients (n = 55) in control group were treated with conventional therapy, and the other 57 cases in treatment group received alprostadil treatment (lOp.g, iv, qd, 14d for a course) besides conventional treatment. Evaluated the changes of neurological function and efficacy, monitored the complications such as cerebral hemorrhage incidence and the coagulation, liver and kidney function changes before and after the treatment. Results 14 days and 28 days after treatment, the NIHSS assessment of the treatment group was siguificantly reduced compared with control group ( P 〈 0. 05 ) ; BI scores of both two groups were increased ( P 〈 0. 05 ), but the treatment group increased more significantly (P 〈 0. 05 ) ; ADL scores of the two groups were reduced after treatment ( P 〈 0. 05 ), but treatment group decreased more significantly (P 〈 0. 05 ) ; the occurrence of adverse events of the two groups had no significant difference. Conclusions Patients with acute cerebral infarction, caused by middle cerebral artery occlusion, got severe illness and the effect of current treatment for them was not as well as expected. Alprostadil lipo-preparations proved to be safe and effective on the treatment of acute cerebral infarction caused by intraeranial arterial stenosis.
出处 《齐齐哈尔医学院学报》 2013年第24期3616-3618,共3页 Journal of Qiqihar Medical University
基金 陕西省科技攻关项目(No.2011K12-05-12)
关键词 前列地尔 急性脑梗死 大脑中动脉闭塞 Alprostadil Middle cerebral artery occlusion Acute cerebral vascular disease
  • 相关文献

参考文献11

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33010
  • 2中华医学会神经病学分会脑血管病学组缺血性脑卒中二级预防指南撰写组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南[J]{H}中华神经科杂志,2010(07):154-160.
  • 3Taogoshi T,Nomura A,Murakami T. Transport of prostaglandin El across the Mood-brain barrier in rats[J].J Pharm Pharmaco1,2005,(01):61-66.
  • 4Kikuchi S,Shinpo K,Niino M. Prostaglandin El protects cultured spinal neurons against the effects of nitric oxide toxicity[J].{H}NEUROPHARMACOLOGY,2002,(05):714-723.
  • 5李保华.前列地尔治疗脑梗死的疗效观察[J].中国实用神经疾病杂志,2007,10(5):16-17. 被引量:15
  • 6DI-Napoli M,Papa F,Bocola V. Prognostic influen of increased C-reactive protein and fibrinogen levels ischemic stroke[J].{H}STROKE,2001,(12):133-138.
  • 7饶明利.中国脑血管病防治指南[M]{H}北京:人民卫生出版社,20071-13.
  • 8Chimowitz MI,Kokkinos J,Stronge J. Stenting versus aggressive medical therapy for intracranial arterial stenosis[J].{H}New England Journal of Medicine,2011,(11):993-1003.
  • 9Wong KS,Li H,Chan YL. Clair Trail[J].{H}Lancet Neurology,2010,(05):489-490.
  • 10Jiang Weijian,YU Wengui,DU Bin. Outcome of patients with 》70% symptomatic intracranial stenosis after wingspan stenting[J].{H}STROKE,2011,(05):1971-1973.

二级参考文献15

共引文献33021

同被引文献30

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部